MCK McKesson
WatchlistMcKesson News
TD Cowen Maintains Outperform on McKesson, Raises Price Target to $563
TD Cowen analyst Charles Ryhee maintains McKesson (NYSE:MCK) with a Outperform and raises the price target from $508 to $563.
How Is The Market Feeling About McKesson?
McKesson's (NYSE:MCK) short percent of float has risen 12.5% since its last report. The company recently reported that it has 1.68 million shares sold short, which is 1.26% of all regular shares that
Sector Update: Health Care Stocks Ease Late Afternoon
Health care stocks were slipping late Tuesday afternoon with the NYSE Health Care Index down 0.4% and the Health Care Select Sector SPDR Fund (XLV) off 0.1%. The iShares Biotechnology ETF (IBB) droppe
McKesson Unionized Warehouse Workers in Sacramento, California, Authorize Strike
McKesson (MCK) warehouse workers in Sacramento, California, represented by the Teamsters have "overwhelmingly" voted to strike if the healthcare services doesn't agree to a new labor deal, the union s
An Intrinsic Calculation For McKesson Corporation (NYSE:MCK) Suggests It's 46% Undervalued
Key Insights Using the 2 Stage Free Cash Flow to Equity, McKesson fair value estimate is US$857 McKesson is estimated to be 46% undervalued based on current share price of US$459 Analyst price ta
Teamsters At McKesson In Sacramento, California, Have Voted To Authorize A Strike If The Company Fails To Reach Agreement On A Fair Contract
Teamsters at McKesson in Sacramento, Calif., have voted overwhelmingly to authorize a strike if the company fails to reach agreement on a fair contract. The 110 warehouse workers are members of Teamst
Purdue Pharma Bankruptcy Settlement Heads to Supreme Court Review
Here's How Much $100 Invested In McKesson 15 Years Ago Would Be Worth Today
McKesson (NYSE:MCK) has outperformed the market over the past 15 years by 7.77% on an annualized basis producing an average annual return of 19.11%. Currently, McKesson has a market capitalization of
McKesson To Go Ex-Dividend On November 30th, 2023 With 0.62 USD Dividend Per Share
November 29th - $McKesson(MCK.US)$ is trading ex-dividend on November 30th, 2023. Shareholders of record on December 1st, 2023 will receive 0.62 USD dividend per share on January 2nd, 2024. The ex
If You Invested $1000 In This Stock 15 Years Ago, You Would Have $13,000 Today
McKesson (NYSE:MCK) has outperformed the market over the past 15 years by 7.27% on an annualized basis producing an average annual return of 18.68%. Currently, McKesson has a market capitalization of
(MCK) - Analyzing McKesson's Short Interest
McKesson's (NYSE:MCK) short percent of float has fallen 18.84% since its last report. The company recently reported that it has 1.49 million shares sold short, which is 1.12% of all regular shares tha
Jefferies U.S. Quant Portfolio - ROIC Stars and High Yield
JP Morgan Maintains Overweight on McKesson, Raises Price Target to $514
JP Morgan analyst Lisa Gill maintains McKesson with a Overweight and raises the price target from $495 to $514.
McKesson Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 11/17/2023 14.2% JP Morgan $495 → $514 Maintains Overweight 11/03/2023 -0.02% Mizuho $427 → $450 Maintains
McKesson (MCK) Announces Availability of FDA-Cleared MCRC Drug
10 Health Care Stocks Whale Activity In Today's Session
This whale alert can help traders discover the next big trading opportunities.Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity scan
Analysts Offer Insights on Healthcare Companies: Icon (ICLR), Becton Dickinson (BDX) and McKesson (MCK)
McKesson(MCK.US) Officer Sells US$4.94 Million in Common Stocks
$McKesson(MCK.US)$ Officer TYLER BRIAN S. sold 10,521 shares of Common Stocks on Nov 13, 2023 at an average price of $470 for a total value of $4.94 million.Source: Announcement What is statement of c
Here's Why We Think McKesson (NYSE:MCK) Might Deserve Your Attention Today
The excitement of investing in a company that can reverse its fortunes is a big draw for some speculators, so even companies that have no revenue, no profit, and a record of falling short, can manage
Edifecs Appoints Former McKesson Leader, Stephen Ayers, as Chief Financial Officer
Seasoned finance executive brings decades of experience focused on growth and metrics-based managementBELLEVUE, Wash.--(BUSINESS WIRE)--Edifecs, Inc., a global health information technology solutions